Concepedia

Shanmugarajan Krishnan

SK

Statistics

Publications

1

Citations

32

H-Index

1

Active since

2024

Affiliations

GlaxoSmithKline (United States)(Current)

Shanmugarajan Krishnan is an author at GlaxoSmithKline (United States).

Publications per year

2024–2024

1

Publications

1

Botensilimab, an Fc-Enhanced Anti–CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy

Dhan Chand, David A. Savitsky, Shanmugarajan Krishnan et al. · Cancer Discovery · 2024 · 32 citations · Full text

1–1 of 1